Page last updated: 2024-10-18

dihydroxyacetone phosphate and Cardiometabolic Syndrome

dihydroxyacetone phosphate has been researched along with Cardiometabolic Syndrome in 1 studies

Dihydroxyacetone Phosphate: An important intermediate in lipid biosynthesis and in glycolysis.
dihydroxyacetone phosphate : A member of the class of glycerone phosphates that consists of glycerone bearing a single phospho substituent.

Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamatani, H1
Takahashi, K1
Yoshida, T1
Soga, T1
Kurachi, H1

Other Studies

1 other study available for dihydroxyacetone phosphate and Cardiometabolic Syndrome

ArticleYear
Differences in the fatty acid metabolism of visceral adipose tissue in postmenopausal women.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:2

    Topics: Adult; Body Composition; Cytokines; Dihydroxyacetone Phosphate; Estradiol; Fatty Acids; Female; Fruc

2014